drugset / Trial / NCT05047341

A Study of Human Substance Balance and Biotransformation of [14C]SHR0302

NCT05047341

Phase 1 Completed 6 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

The study is being conducted to evaluate the absorption, metabolism and excretion of \[14C\]SHR0302 in healthy Chinese adult male subjects.

Timeline

Start
2021-09-07
Primary completion
2021-09-19
Completion
2022-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR0302 Unknown 8 mg

Indications